A importância da microbiota no organismo humano e sua relação com a obesidade

Ana Valeria Garcia Ramirez

Abstract


Este trabalho é uma revisão bibliográfica com o objetivo de descrever a Importância da microbiota no
organismo humano e sua relação com a obesidade. Foram realizadas compilações bibliográficas de
artigos científicos originais e de revisão em revistas indexadas, Arquivos Brasileiros de Cardiologia,
Scielo PubMed/Medline, SeCS. O trabalho descreveu que a microbiota é uma população de
organismos microscópios que habitam o corpo humano. A microbiota intestinal influencia nas doenças
gastrointestinais, e em uma variedade de condições imunológicas, como o diabetes mellitus tipo1,
doenças cardiovasculares, doenças desmielinizantes autoimunes, alergia, asma, e na obesidade.
Há uma associação entre a microbiota intestinal e o peso corporal, havendo uma modificação na
composição das bactérias intestinais em obesos diferente das pessoas com IMC normal. O aumento do
número de microrganismo promotores da saúde no trato gastrointestinal pode ser feito pela alimentação
com prebióticos e probióticos, os quais modificam a composição da microbiota, formando uma barreira
contra as bactérias ruins do ecossistema. O trabalho mostrou que com a integridade intestinal é possível
evitar o surgimento de doenças impedindo a entrada de microrganismos patógenos e antígenos.


Keywords


microbiota intestinal, obesidade, sobrepeso, metabolismo energético, imunidade.

Full Text:

PDF

References


THOMAS DW, GREER FR. American Academy of

Pediatrics Commitee on Nutrition: American Academy of

Pediatrics Section on Gastroentterology, Hepatology, and

Nutrition. Probiotics and prebiotcs in pediatrics. Pediatrics

; 126:1217-31.

BEDANI, R.; ROSSI, E. A. Microbiota Intestinal e

probióticos: implicações sobre o câncer de cólon. Jornal

Português de Gastrenterologia. v. 16, n. 1, p. 19-28. 2009.

DIBAISE, J.K. et al. Gut Microbiota and Its Possible

Relationship with Obesity. Mayo Clinic Proceedings,

Oxford, v.83, no.4, p.460-469, 2008.

FANDIÑO, J.; e colaboradores. Cirurgia Bariátrica:

aspectos clínico-cirúrgicos e psiquiátricos. Rev de Psiq

RS. Vol. 26. Num. 1. jan/abr. 2004. p. 47-51.

FAO; WHO. Health and Nutritional Properties of Profiotics

in Food including Powder Milk with Live Lactic Acid

Bacteria. Argentina, out. 2001.

BOURLIOUX, P.; KOLETZKO, B.; GUARNER, F.;

BRAESCO, V. The intestine and its microflora are

partners for the protection of the host: report on the

Danone Symposium “The Intelligent Intestine,” held in

Paris. American Journal of Clinical Nutrition, v. 78, n. 4, p.

-683. 2003.

WU GD & LEWIS JD (2013). Analysis of the human

gut microbiome and association with disease. Clinical

Gastroenterology Hepatology 11(7):774-777.

ARUMUGAM M, RAES J, PELLETIER E, Le PASLIER D,

YAMADA T, MENDE DR, et al. Enterotypes of the human

gut microbiome. Nature. 2011;473(7346):174-80.

QIN J, Li R, RAES J, Arumugam M, Burgdorf KS,

Manichanh C, et al. A human gut microbial gene catalogue

established by metagenomic sequencing. Nature.

;464(7285):59-65.

TREMAROLI V & BÄCKHED F (2012). Functional

interactions between the gut microbiota and host

metabolism. Nature 489:242-249.

ROBLES Alonso V & Guarner F (2013). Linking the gut

microbiota to human health. British Journal of Nutrition

:S21-S26.

ADLERBERTH I, Wold AE. Establishment of

the gut microbiota in Western infants. Acta

Paediatr.2009;98(2):229–238.

TSUKUMO Daniela M., CARVALHO Bruno M.,

CARVALHO-Filho Marco A., Saad Mário J. A..

Translational research into gut microbiota: new horizons in

obesity treatment. Arq Bras Endocrinol Metab [Internet].

Dez [citado 2016 Jun 22] ; 57( 9 ): 753-753.

ALMEIDA, L. B.; MARINHO, C. B.; SOUZA, C. S.; CHEIB,

V. B. P. Disbiose intestinal. Revista Brasileira de Nutrição

Clínica. v. 24, n. 1, p. 58-65. 2009.

VARAVALLO, M. A.; THOMÉ, J. N.; TESHIMA, E. Aplicação

de bactérias probióticas para profilaxia e tratamento de

doenças gastrointestinais. Semina: Ciências Biológicas e

da Saúde. v. 29, n. 1, p. 83-104. 2008.

BÄCKHED F, FRASER CM, RINGEL Y, et al. (2012).

Defining a healthy human gut microbiome: current

concepts, future directions, and clinical applications. Cell

Host Microbe 12(5):611-622.

GAO Z, TSENG CH, PEI Z et al. Molecular analysis of

human forearm superficial skin bacterial biota. Proc Natl

Acad Sci USA 2007; 104:2927–32.

SILVA, L.P.; NÖRNBERG, J.L. Prebióticos na nutrição de

não-ruminantes.Ciência Rural, v.33, n.4, p.55-65, 2003.

CONTERNO, L. et al. Obesity and the gut microbiota:

does up-regulating colonic fermentation protect against

obesity and metabolic disease? Genes Nutr., v. 6, p. 241-

, 2011.

MUSSO, G., GAMBINO, R.; CASSADER, M. Interactions

between gut microbiota and host metabolismo

predisposing to obesity and diabetes. Annu. Rev. Med.,

v.63, p. 361-380, 2011.

BÄCKHED F, DING H, WANG T, HOOPER LV, KOH GY,

NAGY A, et al. The gut microbiota as an environmental

factor that regulates fat storage. Proc Natl Acad Sci USA.

;101(44):15718-23.

BERNHARD, F. et al. Functional relevance of genes

implicated by obesity genome-wide association study

signals for human adipocyte biology. Diabetologia. Berlin,

v. 56, p. 311-322, 2013.

SARTOR, R.B. — Microbial influences in inflammatory

bowel disease. Gastroenterology, 134: 577-94, 2008.

FAVA F, GITAU R, GRIFFIN BA, et al. (2013). The type

and quantity of dietary fat and carbohydrate alter faecal

microbiome and short-chain fatty acid excretion in a

metabolic syndrome ‘at-risk’ population. International

Journal of Obesity 37(2):216-223.

CLARKE SF, MURPHY EF, NILAWEERA K, et al. (2012).

The gut microbiota and its relationship to diet and obesity.

Gut Microbes 3(3):186-202.

MOLINARO, PASCHETTA E, CASSADER M, et al.

(2012). Probiotics, prebiotics, energy balance, and obesity

– mechanistic insights and therapeutic implications.

Gastroenterology Clinics of North America 41(4):843-854.

LEY RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial

ecology: human gut microbes associated with obesity.

Nature. 2006;444(7122):1022-3.; 24.

LEY RE, BÄCKHED F, TURNBAUGH P, LOZUPONE

CA, Knight RD, Gordon JI. Obesity alters gut microbial

ecology. Proc Natl Acad Sci USA. 2005;102(31):11070-5.

VANDENPLAS Y, VEEREMAN-WAUTERS G, DEGREEF

E, et al. Probiotcs and prebiotics in prevention and

treatment of diseases in infants and children. J Pediatr

(Rio J) 2011; 87(4):292-300.,

KOSIEWICZ MM, ZIRNHELD A L, Alard P. Gut microbiota,

immunity, and disease: a complex relationship. www.

frontiersin.org. Front Microbial 2011, 2:1-11.

ZEYREK CD, ZEYREK F, SEVINC E, DEMIR E. Prevalence

of asthma and allergic diseases in Sanliurfa, Turkey, and

the relation to environmental and socioeconomic factors:

is the hygiene hypothesis enough? J Investig Allergol

ClinImmunol 2006; 16:290-295.

SEISKARI T, KONDRASHOVA A, VISKARI H et al. The

EPIVIR study group. Allergic sensitization and microbial

load – a comparison between Finland and Russian

Karelia. Clin Exp Immunol 2007; 148:47-52.

CRITTENDEN, R.G. Prebiotics. In: TANNOCK, G.W., ed.

Probiotics: a critical review. Norfolk: Horizon Scientific

Press, 1999. p.141-156.

SANDERS ME, Guarner F, Guerrant R, et al. (2013). An

update on the use and investigation of probiotics in health

and disease. Gut 62(5):787-796.

WEICHSELBAUM E (2009). Probiotics and health: a

review of the evidence. Nutrition Bulletin 34:340-373.

GIBSON GR, Probert HM, Loo JV, Rastall RA, Roberfroid

MB. Dietary modulation of the human colonic microbiota:

updating the concept of prebiotics. Nutr Res Rev.

;17:259-75.

MANNING, T. S.; GIBSON, G. R. Microbial-gut interactions

in health and disease. Prebiotics. Best Practice Research

Clinical Gastroenterology, v. 18, n. 2, p. 287-298, 2004.

GIBSON, G.R.; ROBERFROID, M.B. Dietary modulation

of the human colonic microbiota: introducing the concept

of prebiotics. J. Nutr., Bethesda, v.125, p.1401-1412,

MAGNE, F. et al. Fecal microbial community in preterm

infants. J. Pedriat. And Nutr., v.41, p.386-392, 2005.

EISEMAN B, SILEN W, BASCOM GS, et al. Fecal enema

as an adjunct in the treatment of pseudomembranous

enterocolitis. Surgery. 1958 44:854–859.

TURNBAUGH PJ, LEY RE, MAHOWALD MA, MAGRINI

V, MARDIS ER, Gordon JI. An obesity-associated gut

microbiome with increased capacity for energy harvest.

Nature. 2006;444(7122):1027-31.;

TURNBAUGH PJ, BÄCKHED F, FULTON L, GORDON

JI. Diet-induced obesity is linked to marked but reversible

alterations in the mouse distal gut microbiome. Cell Host

Microbe. 2008; 3(4):213-23.

FANDIÑO, J.; Segala, A. Indicações e contra-indicações

para realização das operações bariátricas. Rev Bras de

Psiq. Vol. 4. 2002. p. 68-72.;

GIBSON, G.R.; FULLER, R. Aspects of in vitro and in vivo

research approaches directed toward identifying probiotics

and prebiotics for human use. J. Nutr., Bethesda, v.130,

p.391S-394S, 2000.

BRANDT, K. G.; SAMPAIO, M. M. S. C.; MIUKI, C. J.

Importância da microflora intestinal. Pediatria. v. 2, n. 28,

p.117-127. 2006.




DOI: http://dx.doi.org/10.22565/ijn.v10i4.327

Refbacks

  • There are currently no refbacks.